Primordial role of CD34+38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 568-581

  Henon Ph ^a,c   Sovalat, H ^a   Becker, M ^a   Arkam, Y ^a   Ojeda Uribe, M ^a   Raidot, J P ^b   Hesseini, F ^b   Wunder, E ^a   Bouderont, D ^b   Audhuy, B ^a  

^a CENTRE HOSPITALIER DE MULHOUSE   (France)

^b Pasteur Hospital   (France)

^c Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

Autologous blood cell transplantation; CD33 subsets; CD34+ cells; CD38 subsets; Engraftment kinetics; Haemopoietic recovery

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD AUTOTRANSFUSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL TRANSPLANTATION; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; HUMAN; LEUKAPHERESIS; LEUKEMIA; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REGRESSION ANALYSIS; RETICULOCYTE COUNT;

ADOLESCENT; ADP-RIBOSYL CYCLASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; BLOOD CELL COUNT; BLOOD TRANSFUSION, AUTOLOGOUS; COLONY-FORMING UNITS ASSAY; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NAD+ NUCLEOSIDASE; PROSPECTIVE STUDIES; WHOLE-BODY IRRADIATION;

EID: 7844249241     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01066.x     Document Type: Article

References (42)

1. Andrews, R.G., Singer, J.W. & Bernstein, I.D. (1989) Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and high-scatter properties. Journal of Experimental Medicine, 169, 1721-1731.
2. Bender, J.G., To, L.B., Williams, S. & Schwartzberg, L.S. (1992) Defining a therapeutic dose of peripheral blood stem cells. Journal of Hematotherapy, 1, 329-341.
3. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R, Chaunley, T., Klarnet, J., Mongomery, P., Petersdorf, S., Weiden, P., Whiterspoon, R. & Buckner, C.D. (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology, 13, 2547-2555.
4. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, R., Lynch, M., Tigano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825-831.
5. + cell subsets and platelet recovery alter PBSC autograft. (Letter). Bone Marrow Transplantation, 16, 855-856.
6. + cells mobilized by G-CSF. Bone Marrow Transplantation, 21, 561-568.
7. Cortelazzo, S., Viero, P. & Bellavita, P. (1995) Granulocyte colony-stimulating factor following peripheral-blood progenitor cell transplant in non-Hodgkin's lymphoma. Journal of Clinical Oncology, 13, 935-941.
8. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A.C., Pileri, A. & Bonadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet, ii, 580-585.
9. Harvey, K., Higgins, N., Akard, L., Chang, Q., Jansen, J., Thompson, J., Dugan, M., Rizzo, M.T. & English, D. (1997) Lineage committment of HLA-DR/CD38 defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence. Journal of Hematotherapy, 6, 243-252.
10. Haynes, A., Hunter, A., McQuaker, G., Anderson, S., Bienz, N. & Russel, N.H. (1995) Engraftment characteristics of peripheral blood stem cell mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplantation, 16, 359- 363.
11. Hénon, Ph. (1993) Peripheral blood stem cell transplantation: past, present and future. Stem Cells, 11, 154-172.
12. Hénon, Ph. (1994) Peripheral blood stem cell mobilization: a critical review. Hematopoietic Stem Cells: the Mulhouse Manual (ed. by E. Wunder, H. Sovalat, P. R. Hénon and S. Serke), pp. 101-111. Alpha Med Press, Dayton, Ohio.
13. Hénon, P.R., Liang, H., Beck-Wirth, G., Eisenmann, J.C., Lepers, M., Wunder, E. & Kandel, G. (1992) Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplantation, 9, 285-291.
14. + cell populations from normal human peripheral blood. Stem Cells, 12, 187-197.
15. +, CD38 hematopoietic stem cells. Blood, 83, 1515-1526.
16. Kessinger, A., Armitage, J.O., Landmark, J., Smith, D. & Weisenburger, D. (1988) Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood, 71, 723-727.
17. Klumpp, T.R., Mangan, K.F., Goldberg, S.L., Pearlmann, E.S. & McDonald, J.S. (1995) Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. Journal of Clinical Oncology, 15, 1323-1327.
18. Körbling, M., Przepiorka, D., Huh, Y.O., Engel, H., Van Besien, K., Giralt, S., Andersson, B., Kleine, H.D., Seong, D., Deisseroth, A.B., Andreeff, M. & Champlin, R. (1995) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood, 85, 1659-1665.
19. Legros, M., Fleury, J., Bay, J.O., Choufi, B., Basile, M., Condat, P., Glenat, C., Communal, Y., Tavernier, F., Bons, J.M., Chollet, P., Plagne, R. & Chassagne, J. (1997) rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial. Bone Marrow Transplantation, 19, 209 213.
20. Linch, D.C., Milligan, D.W., Winfield, D.A., Kelsey, S.M., Johnson, S.A., Littlewood, T.J., Smith, G.M., Hutchinson, R.M., Goldstone, A.H., Fielding, A.K. & Hudson, G.V. (1997) G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. British Journal of Haematology, 99, 933-938.
21. Nakamura, Y., Noma, M., Kidoro, M., Kobayashi, N., Takei, M., Kurashima, S., Mukaiyama, T. & Kato, S. (1994) Expression of CD33 antigen on normal human activated T lymphocytes. Blood, 83, 1442-1443.
22. Pierelli, L., Iacone, A., Quaglietta, A.M., Nicolucci, A., Menichella, G., Panici, P.B., D'Antonio, D., De Laurenzi, A., De Rosa, L., Fioritoni, G., Indovina, A., Leone, G., Majolino, I., Montuoro, A., Scimè, R. & Torlontano, G. (1994) Haematopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study. British Journal of Haematology, 86, 70-75.
23. Pierelli, L., Scambia, G., Menichella, G., D'Onofrio, G., Salerno, G., Panici, P.B., Foddai, M.L., Vittori, M., Lai, M. Ciarli, M., Puglia, G., Mancuso S. & Bizzi, B. (1996) The combination of erythropoietin and granulocyte colony-stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation, British Journal of Haematology, 92, 287-294.
24. + peripheral blood progenitors are myeloperoxydase-negative and noncycling irrespective of CD33 or CD13 coexpression. Experimental Hematology, 25, 246-251.
25. + bone marrow cells. Blood, 84, 1473-1481.
26. Sakabe, H., Ohmizono, Y., Tanimukai, S., Kimura, T., Mori, K.J., Abet, T. & Sonoda, Y. (1997) Functional differences between subpopulations of mobilized peripheral blood-derived CD34 cells expressing different levels of HLA-DR. CD33, CD38 and C-kit antigens. Stem Cells, 15, 73-81.
27. + cell determination for peripheral blood progenitor cell transplantation: how many is enough? (Abstract). Experimental Hematologly, 24, 1024.
28. Shimazaki, C., Oku, N., Uchiyama, H., Yamagata, N., Tatsumi, T., Hirata, T., Ashiara, E., Okawa, K., Goto, H., Inaba, T., Fujita, N., Haruyama, H. & Nakagawa, M. (1994) Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplantation, 13, 271-175.
29. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stern, A.C., Lansdorp, P.M., Bonadonna, G. & Gianni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
30. 8/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation. Experimental Hematology, 23, 1581-1588.
31. + enumeration. Journal of Hematotherapy, 6, 85-89.
32. Sutherland, H.J., Eaves, C.J., Eaves, A.C., Dragowka, W. & nsdorp, P.M. (1989) Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood, 74, 1563-1570.
33. Suzue, T., Takaue, Y., Watanabe, A., Kawano, Y., Watanabe, T., Abe, T., Kuroda, Y., Matsushita, T., Kikuta, A., Iwai, A., Shimokawa, T., Eguchi, H., Murakami, T., Kosaka, Y., Kudo, T., Shimizu, H., Koizumi, S. & Fujimoto, T. (1994) Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan. Experimental Hematology, 22, 1997-2202.
34. Takamatsu, Y., Harada, M., Teshima, T., Makino, S., Inaba, S., Akashi, K., Shiguya, T. & Niho, Y. (1995) Relationship of infused CFU-GM and CFU-MK mobilized with chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Experimental Hematology, 23, 8-13.
35. Tarella, C., Castellino, C., Locatelli, F., Caracciolo, D., Corradini, P., Falda, M., Novarino, A., Tassi, V. & Pileri, A. (1998) G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplantation, 21, 401-407.
36. - progenitor cells. Blood, 77, 1218-1227.
37. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., Ho, J.Q.K., Dart, G.W., Horvath, N., Davy, M.L.J., Olweny, C.L.M., Abdi, E. & Juttner, C.A. (1992) Comparison of hematological recovery times and supportive care requirements of covery phase following autologous peripheral blood stem cell transplants, autologous bone marrow transplants, and allogeneic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
38. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1995) Peripheral blood stem cell transplants for MM: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, 588-596.
39. Urashima, M., Ohkawara, J., Hoshi, Y., Kato, Y., Uchiyama, H., Kamijo, M., Akatsuka, J. & Maekawa, K. (1994) Peripheral blood progenitor cell transplantation estimated by three-colour (CD34, HLA-DR, CD33) flow cytometry. Acta Haematologica, 92, 23-28.
40. Van der Walle, E., Richel, D.J., Holtkamp, M.J., Slaper-Cortenbach, I.C.M., Van der Schoot, C.E., Dalesio, O., Nooijen, W.J., Schoragel, J.H. & Rodenhuis, S. (1994) Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size. Annals of Oncology, 5, 795-802.
41. - cells in the graft predicts the kinetics of hematopoietic reconstitution following autologous or allogeneic bone marrow transplantation. (Abstract). Blood, 90, (Suppl. 1), 394a.
42. Weaver, C.H., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L. & West, W. (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961-3969.